| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |